A universal vaccine which will protect people against all future variants of the lethal coronavirus! How does that sound? Well, a team of Indian scientists claims to have designed a peptide vaccine which can be effective against all the variants of SARS-COV-2.
"This NeoCov is very different from SARS-CoV virus (sarbecovirus) and belongs to merbecovirus which is a different genus.
The virus uses the spike protein to latch on to and enter the cells it infects. The Omicron spike protein has 37 mutations that distinguish it from the first SARS-CoV-2 isolates in 2020.
"We will need to learn to manage it through a sustained and integrated system for acute respiratory diseases, which will provide a platform for preparedness for future pandemics."
Some reports also have suggested that people living in areas with lower vaccination rates are at greater risk of getting co-infected. In addition, the risk of co-infection has been found more among the elderly, those with co-morbidities and a compromised immune system.
While 50 per cent of the adult population in India has received two doses of the vaccine, and 84 per cent has received one dose, children are yet to be inoculated in the country.
FIH will keep monitoring the situation and take a decision about the potential staging of the 2021 FIH Hockey Women's Junior World Cup as soon as it will be possible to do so, the report said.
The new variant of Covid-19 virus, being called as Delta 'Plus' is in negligible numbers in India. Chief of Odisha Directorate of Medical Education and Training (DMET), CBK Mohanty shared this information on Monday (Oct 25).
London: The Brazil variant (also known as P1) is likely to be more transmissible than previous strains of Coronavirus and able to evade immunity gained from infection with other strains,…
New York: Scientists have revealed how a highly infectious variant of SARS-CoV-2 virus binds to host but succumbs to antibodies later, a discovery that could help in the development of…
London: People infected with the B117 variant of the coronavirus did not experience more severe illness and were not more likely to die, according to a new study published in…